$1M raised to support IRIC’s research efforts to vanquish cancer
The eIF4E factor reveals itself in a new way - summary of the article from the Borden Lab in Cell Reports
Audacious 2019 >
Scientific publication >
EVENT >
Nomination >

$1M raised to support IRIC’s research efforts to vanquish cancer

The eIF4E factor reveals itself in a new way - summary of the article from the Borden Lab in Cell Reports

Calendar

  • June 20, 2019 09:00BIM 6064C - Proteomics
  • June 21, 2019 09:00BIM 6064C - Structural biology
  • June 21, 2019 13:00BIM 6064C - How to write a grant
AEC v1.0.4

Recent Publications

Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.Da Costa EM et al.J. Exp. Clin. Cancer Res. 2019. > More

Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs.Wang W et al.Proc. Natl. Acad. Sci. U.S.A. 2019. > More

The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.Angenendt L et al.Leukemia 2019. > More

Research

Research

Accelerating the discovery of new, more effective therapies to treat cancer > More

https://www.iric.ca/en/students/why-study-at-iric/

Students

An ultra-modern training centre for the next generation of scientists at the heart of Université de Montréal > More

https://www.iric.ca/en/supporting-iric/fundraising-campaign/

Support IRIC

Multiple opportunities to participate in our discoveries > More

Follow IRIC

Logo UdeM